MEDICORTEX FINLAND OY
Medicortex Finland is developing the first, non-invasive, point-of-care diagnostic test for Traumatic Brain Injury and concussion. Problem: A Traumatic Brain Injury (TBI) happens when an external force to the head causes damage to the brain tissue. Mild TBI, which is also known as concussions, are difficult to diagnose with current diagnostic methods such as CT and MRI scans. Solution: Medicortex is working towards the identification of brain injury biomarkers and their incorporation into a h... and-held diagnostic kit, which will give a reliable result rapidly and will not require medical professionals to interpret the result. Business: We identified a unique biomarker that can be detected from urine and saliva. With strong clinical evidence and protected idea, we are willing to negotiate with bigger diagnostic companies for collaboration on manufacturing and distribution. Market: Customers include hospitals, emergency rooms, paramedics and first responders, military paramedics, sports teams (especially contact sports such as rugby, American football, ice hockey), pharma and insurance companies. Accomplishments: We have reached Phase II Clinical studies of the biomarker. The company received grant funding from US Department of Defense, European Union and Finnish Government.
MEDICORTEX FINLAND OY
Industry:
Biotechnology Clinical Trials Health Care Medical
Founded:
2014-01-01
Address:
Turku, Western Finland, Finland
Country:
Finland
Website Url:
http://www.medicortex.fi
Total Employee:
1+
Status:
Active
Contact:
+358 (0) 400 488 817
Email Addresses:
[email protected]
Total Funding:
1.91 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Mobile Non Scaleable Content Nginx Microsoft Exchange Online
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Employees Featured
Founder
Investors List
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Medicortex Finland Oy
European Innovation Council
European Innovation Council investment in Grant - Medicortex Finland Oy
Ran Weinstock
Ran Weinstock investment in Equity Crowdfunding - Medicortex Finland Oy
Official Site Inspections
http://www.medicortex.fi Semrush global rank: 5.49 M Semrush visits lastest month: 1.56 K
- Host name: server2.verkkovaraani.fi
- IP address: 35.228.83.48
- Location:
- Latitude: 47
- Longitude: 8
- Timezone: Europe/Vaduz
